Search Results - "Giler, Robertino Mera"

Two years of Truvada for pre‐exposure prophylaxis utilization in the US by Flash, Charlene, Landovitz, Raphael, Mera Giler, Robertino, Ng, Leslie, Magnuson, David, Bush Wooley, Staci, Rawlings, Keith

“…Introduction Truvada® (TVD) was approved in July 2012 by the US FDA for pre‐exposure prophylaxis (PrEP) in combination with safer sex practices to reduce the…”
Get full text

Small-area spatial-temporal changes in pre-exposure prophylaxis (PrEP) use in the general population and among men who have sex with men in the United States between 2012 and 2018 by Mouhanna, Farah, Castel, Amanda D., Sullivan, Patrick S., Kuo, Irene, Hoffman, Heather J., Siegler, Aaron J., Jones, Jeb S., Mera Giler, Robertino, McGuinness, Pema, Kramer, Michael R.

“…Oral emtricitabine/tenofovir disoproxil fumarate was approved for use as pre-exposure prophylaxis (PrEP) by the U.S. Food and Drug Administration in 2012. We…”
Get full text

Claims-Based Algorithm to Identify Pre-Exposure Prophylaxis Indications for Tenofovir Disoproxil Fumarate and Emtricitabine Prescriptions (2012-2014): Validation Study by Sullivan, Patrick Sean, Mera-Giler, Robertino M, Bush, Staci, Shvachko, Valentina, Sarkodie, Eleanor, O'Farrell, Daniel, Dubose, Stephanie, Magnuson, David

“…Background To monitor the use of tenofovir disoproxil fumarate and emtricitabine (TDF/FTC) and related medicines for pre-exposure prophylaxis (PrEP) as HIV…”
Get full text

The prevalence of pre-exposure prophylaxis use and the pre-exposure prophylaxis–to-need ratio in the fourth quarter of 2017, United States by Siegler, Aaron J., Mouhanna, Farah, Giler, Robertino Mera, Weiss, Kevin, Pembleton, Elizabeth, Guest, Jodie, Jones, Jeb, Castel, Amanda, Yeung, Howa, Kramer, Michael, McCallister, Scott, Sullivan, Patrick S.

“…The number of individuals who have started a regimen for HIV pre-exposure prophylaxis (PrEP) in the United States is not well characterized but has been on the…”
Get full text

Trends in the use of oral emtricitabine/tenofovir disoproxil fumarate for pre-exposure prophylaxis against HIV infection, United States, 2012–2017 by Sullivan, Patrick S., Giler, Robertino Mera, Mouhanna, Farah, Pembleton, Elizabeth S., Guest, Jodie L., Jones, Jeb, Castel, Amanda D., Yeung, Howa, Kramer, Michael, McCallister, Scott, Siegler, Aaron J.

“…Pre-exposure prophylaxis (PrEP) with oral emtricitibine/tenofovir disoproxil fumarate (TDF/FTC) reduces the risk of HIV infection by >90% when taken as…”
Get full text

Policy- and county-level associations with HIV pre-exposure prophylaxis use, the United States, 2018 by Siegler, Aaron J., Mehta, C. Christina, Mouhanna, Farah, Giler, Robertino Mera, Castel, Amanda, Pembleton, Elizabeth, Jaggi, Chandni, Jones, Jeb, Kramer, Michael R., McGuinness, Pema, McCallister, Scott, Sullivan, Patrick S.

“…HIV pre-exposure prophylaxis (PrEP) is highly efficacious, and yet most individuals indicated for it are not currently using it. To provide guidance for health…”
Get full text

Remdesivir for Severe Coronavirus Disease 2019 (COVID-19) Versus a Cohort Receiving Standard of Care by Olender, Susan A, Perez, Katherine K, Go, Alan S, Balani, Bindu, Price-Haywood, Eboni G, Shah, Nirav S, Wang, Su, Walunas, Theresa L, Swaminathan, Shobha, Slim, Jihad, Chin, BumSik, De Wit, Stéphane, Ali, Shamim M, Soriano Viladomiu, Alex, Robinson, Philip, Gottlieb, Robert L, Tsang, Tak Yin Owen, Lee, I-Heng, Hu, Hao, Haubrich, Richard H, Chokkalingam, Anand P, Lin, Lanjia, Zhong, Lijie, Bekele, B Nebiyou, Mera-Giler, Robertino, Phulpin, Chloé, Edgar, Holly, Gallant, Joel, Diaz-Cuervo, Helena, Smith, Lindsey E, Osinusi, Anu O, Brainard, Diana M, Bernardino, Jose I

“…Abstract Background We compared the efficacy of the antiviral agent, remdesivir, versus standard-of-care treatment in adults with severe coronavirus disease…”
Get full text

Evidence of an Association of Increases in Pre-exposure Prophylaxis Coverage With Decreases in Human Immunodeficiency Virus Diagnosis Rates in the United States, 2012–2016 by Smith, Dawn K, Sullivan, Patrick S, Cadwell, Betsy, Waller, Lance A, Siddiqi, Azfar, Mera-Giler, Robertino, Hu, Xiaohong, Hoover, Karen W, Harris, Norma S, McCallister, Scott

“…Abstract Background Annual human immunodeficiency virus (HIV) diagnoses in the United States (US) have plateaued since 2013. We assessed whether there is an…”
Get full text

SAT-331-Use of machine learning to predict diagnosis codes for non-alcoholic steatohepatitis in administrative healthcare data by Telep, Laura, Zhang, Chi, Djedjos, Stephen, Myers, Robert, Giler, Robertino Mera, Hubbard, Alan, Chokkalingam, Anand

Get full text

Validation of a claims-based algorithm to identify pre-exposure prophylaxis indications for tenofovir disoproxil fumarate/emtricitabine prescriptions, United States, 2012-2014: algorithm validation by medical records review by Sullivan, Patrick Sean, Mera-Giler, Robertino M, Bush, Staci, Shvachko, Valentina, Sarkodie, Eleanor, O'Farrell, Daniel, Dubose, Stephanie, Magnuson, David

“…To monitor the use of tenofovir disoproxil fumarate/emtricitabine (TDF/FTC) and related medicines for pre-exposure prophylaxis (PrEP) as HIV prevention using…”
Get full text

Policy and County-Level Associations with HIV Preexposure Prophylaxis Use, United States, 2018 by Siegler, Aaron J., Mehta, C. Christina, Mouhanna, Farah, Giler, Robertino Mera, Castel, Amanda, Pembleton, Elizabeth, Jaggi, Chandni, Jones, Jeb, Kramer, Michael R., McGuinness, Pema, McCallister, Scott, Sullivan, Patrick S.

Get full text

Trends in use of oral emtricitabine/tenofovir disoproxil fumarate for pre-exposure prophylaxis against HIV infections, United States, 2012-2017 by Sullivan, Patrick S, Giler, Robertino Mera, Mouhanna, Farah, Pembleton, Elizabeth, Guest, Jodie, Jones, Jeb, Castel, Amanda, Yeung, Howa, Kramer, Michael, McCallister, Scott, Siegler, Aaron

Get full text

The prevalence of PrEP use and the PrEP-to-need ratio in the fourth quarter of 2017, United States by Siegler, Aaron J., Mouhanna, Farah, Giler, Robertino Mera, Weiss, Kevin, Pembleton, Elizabeth, Guest, Jodie, Jones, Jeb, Castel, Amanda, Yeung, Howa, Kramer, Michael, McCallister, Scott, Sullivan, Patrick S.

Get full text

1963. PrEP Significantly Reduces the Rate of New HIV Diagnoses in US Metropolitan Statistical Areas Independent of Treatment as Prevention (2012–2017) by Mera-Giler, Robertino M, Das, Moupali, Hawkins, Trevor, Magnuson, David, Asubonteng, Julius, McCallister, Scott

“…Abstract Background Tenofovir/Emtricitabine (TVD) was approved for a Pre-exposure Prophylaxis (PrEP) indication in the United States in July 2012. Biomedical…”
Get full text

Contrasting serum biomarker profiles in two Colombian populations with different risks for progression of premalignant gastric lesions during chronic Helicobacter pylori infection by Whary, Mark T., Avenia, Jose M. Restrepo, Bravo, Luis E., Lofgren, Jennifer L., Lertpiriyapong, Kvin, Mera-Giler, Robertino, Piazuelo, M. Blanca, Correa, Pelayo, Peek, Richard M., Wilson, Keith T., Fox, James G.

“…•Coastal Colombians have lower Helicobacter pylori-associated gastric cancer compared to the Andes despite comparable infection and gastritis.•Lesion…”
Get full text